Veracyte

$39.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.61 (-3.92%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Veracyte and other stocks, options, and ETFs commission-free!

About VCYT

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. Read More It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA. The listed name for VCYT is Veracyte, Inc. Common Stock.

Employees
354
Headquarters
South San Francisco, California
Founded
2006
Market Cap
2.23B
Price-Earnings Ratio
Dividend Yield
Average Volume
465.92K
High Today
$42.06
Low Today
$39.34
Open Price
$41.24
Volume
506.99K
52 Week High
$44.64
52 Week Low
$13.90

Collections

VCYT Earnings

-$0.24
-$0.16
-$0.08
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Available Nov 2, After Hours

You May Also Like